ARS Pharmaceuticals, Inc. (BOATS:SPRY) IPO

ARS Pharmaceuticals, Inc.

IPO

Went public as Silverback Therapeutics, Inc. Priced at US$21.00 a share on Dec 3, 2020.

Price
US$21.00 a share
Shares offered
11,500,000 shares of common stock
Offering size
US$241.5 million
Underwriters' option
Up to 1,725,000 more shares
Underwriters
Goldman Sachs & Co. LLC, SVB Leerink, Stifel, H.C. Wainwright & Co. · In the order on the cover

Steps

StepWhen
Draft sent to the SEC in confidenceOct 2, 2020
Filed publiclyNov 10, 2020
Amended twiceNewest Dec 3, 2020
Shares registered with an exchangeDec 1, 2020
Declared effective by the SECDec 3, 2020
Final prospectus, with the priceDec 4, 2020

From the cover of the final prospectus (424B4) filed Dec 4, 2020